by Rick Robinson
Originally posted on IBM's Midsize Insider blog on December 27th, 2012.
-------
Building and retaining customer loyalty is one of the biggest challenges that midsize firms face. Conventional wisdom, after all, has it that consumers are inherently fickle. They are hard to win over and all too easy to lose. They may love you one day and turn their backs on you the next.
But the conventional wisdom is mostly wrong. Customers, by and large, would like to be loyal. After all, sticking with a trusted company or brand makes their life a good deal easier. To walk into, say, a grocery store to buy a new product is to be confronted with too many choices. How do you choose among dozens of similar products or services? Far easier to just go in and get a brand you know you can depend on.
For companies, however, this does not make loyalty easy to build or keep.
Customer by Customer, Analytics Add Up
Establishing and retaining customer loyalty is all about listening to your customers. For a small storefront business this can be relatively simple, if not always easy. Customers will come right up to the counter and give you an earful.
For midsize firms it can be more complicated. The most important customers may not be the most vocal ones. But analytic solutions from IBM can help make the listening process more reliable and effective.
Analytics tools can help a company determine what makes for satisfied--or dissatisfied--customers. And analytics can provide an ongoing picture of customers and their reactions. Potential problems, or opportunities, can be identified and tracked in real time. Thus, firms can act promptly to retain customers at risk or identify new customers who can be brought into the fold.
Likewise, analytics can help to identify your best customers, and help you build a stronger relationship with them.
Detecting Subtle Signals
Analytics are powerful because they don't just track what customers say, but also what they do. Big data has become a popular buzzword in the tech world. When it comes to customer behavior, however, big data is a reality as well as an opportunity that midsize firms should not ignore.
From subtle trends in buying behavior to comments on social media such as Facebook or Twitter, customers and potential customers are constantly sending signals about what they like and what they want more of. Combining these different signals can provide information that would have otherwise remained undiscovered.
IBM's analytics tools can help you hear what your customers are thinking, so you can respond to their needs more quickly.
Showing posts with label Smart Analytics. Show all posts
Showing posts with label Smart Analytics. Show all posts
Thursday, December 27, 2012
Wednesday, September 5, 2012
Cognos 10 Active Reports Workshop - Presented by NES
Cognos 10 Active Reports Workshop - Presented by NES
Tuesday, September 18th, 2012
WHERE:
IBM Waltham TEC Center
404 Wyman Street
North Entrance
Waltham, MA 02454
WHEN:
Tuesday, September 18th,
9am to 2pm EDT
>Register Now!
NES has over 30 years' experience with IBM business solutions across a wide range of businesses and industries and is prepared to answer questions specific to your needs.
Katy Dallas
617-372-6061
|
Gone are the days of working from a cubicle or traditional office. People are on the road more than ever and need the same type of up-to-date information they would have in the office.
Join us on Tuesday, Sept. 18 from 9:00 AM to 2:00 PM in Waltham, MA for a hands-on workshop that will arm you with all the knowledge you need to have your remote employees up and running on Cognos 10!
Truly Portable Business Intelligence
|
Thursday, August 23, 2012
Think BIG @ibm_iod 2012: Oct. 21-25. Las Vegas.
Information On Demand 2012 is THE place to learn how you can "think big" and make a difference in your organization. Learn more and register at ibm.com/events/informationondemand
Wednesday, August 1, 2012
@IBM @developerworks: Big Data #Analytics for #Video, #Mobile, #Social Game Monetization
Understand and influence profitable consumer behavior.
by Kimberly Chulis, CEO and Co-founder, Core Analytics, LLC
This article was originally published on IBM's developerWorks blog on July 17th , 2102
Summary: The game industry is experiencing tremendous change as the traditional gaming landscape expands to include new types of games, platforms, and players. Game developers and brands have an opportunity to apply these big data analytics techniques to capture rich and varied behavioral and multi-structured game and player data. You can store this data in noSQL databases and integrate it with relational transactional databases to gain keen competitive advantages through deeper and more actionable insights.
Game industry changes and trends
There is a revolution happening in the game industry. The sheer size of the global game industry is staggering. According to industry analyst Colin Sebastian for RW Baird, video games generated US$60 billion in revenues in 2011 and are expected to reach US$80 billion by 2014. While exact projections and expected growth patterns by game type diverge depending on sources, some herald the video game industry as the anticipated mass media channel of the decade. Computer games are forecasted at US$20 billion, and social games are anticipated to bring in US$2 billion this year (2012). While these numbers indicate that the current largest share of market belongs to the video game industry, an important preferential shift and player demographic change is occurring that is expected to result in a partial decline in popularity of core video games and a rapid decline in the console variety.
Social games are now offered at a fraction of the price through social platforms, such as Facebook, and are played on various mobile platforms, such as Android and iOS. These games differ from traditional video and massively multiplayer online (MMO) games. Traditional hardcore gamers are predominantly male, between the ages of 18 and 34, who buy boxed console and computer games that they pay for with cash and credit cards and play solo or within a limited interactive environment. The rapid adoption of mobile games represents a fundamental change in the gaming landscape, expanding who, how, and why gamers are playing. Social gamers tend to be 54 percent female, use mobile payments and PayPal for purchases, and play across platforms and devices. Of further interest are stark differences that are emerging in game revenue patterns across devices. Recent surveys conducted by Newzoo point to iOS games generating 85 percent of in-game revenues over Android and other platforms.
Industry analysis points to an expected decline in console games and related hardware and apparatus sales, with web-based games becoming the go-to gaming platform. This trend will be parallel to continued growth in video games played on the computer and to explosive growth in mobile games, with the latter expected to hit US$16 billion in revenues by 2016, according to ABI Research. This translates into big opportunity for analytics providers.
Game analytics
Although the global game industry is now larger than the music industry and on par with the size of the film industry, game developers are only starting to adopt advanced analytics to support game development, product design, targeted marketing efforts, and data-driven in-game monetization optimization. The corresponding game analytics industry is still greatly underserved. A list of niche analytics vendors for social and mobile games continues to expand, with representation by Kontagent, Flurry, Mixpanel, Totango, Claritics, and Google Analytics. There are far fewer vendors focusing on the computer and MMO games, and no single analytics provider appears to focus on delivering cross-game platform analytics.
Many of these off-the-shelf products adequately provide the expected standard list of metrics for social games), including:
- Daily active users (DAU)
- Monthly active users (MAU)
- A combined DAU/MAU ratio
- Engagement, which measures time spent playing a game
- K-factor, which is an infection rate of viral game growth as the core and casual player base expands
- Average revenue per user (ARPU)
- Lifetime value (LTV), which captures a player's value to the game based on in-game purchases and other monetization-related behaviors, player influence on virality, and net game evangelism
Game monetization
Traditionally, video and social games have had distinctly different business models. Now there is more of a convergence of business monetization approaches between game types. Historically, video games relied on a subscription-based model requiring gamers to make an upfront game purchase and subscribe to an ongoing monthly fee. This business model is being replaced by some games with the testing of free-to-play models that closely follows the emerging freemium model typically offered by social games. Currently the terms mobile and social are often used interchangeably; however, they will likely become distinct game genres as game distribution patterns develop. They will expand game access and greatly increase the corresponding potential player universe. Whereas some games today are available only on certain sites such as Facebook, on single platforms such as computer or Xbox, or on specific devices such as iPhone or iPad, eventually many game titles will be released across more platforms in a more site- and device-agnostic fashion.
Social and mobile games make money (monetize) in a few ways, and related business and monetization models are changing dynamically. Some games, such as the iOS-based W.E.L.D.E.R. word game, charge an initial purchase subscription fee but will likely eventually move to a freemium model. Other games, such as those on Facebook, rely on the sale of virtual goods. Games such as Zynga’s CityVille, for example, fit the mold where players use actual money or Facebook Credits to purchase in-game virtual goods to help them perform better, gain advantages, get premium access, and move to higher levels (level-up) faster. A third popular form of game monetization is in-game advertising. Companies such as TapJoy offer in-game banner ads, video offers, and full-page interstitial advertisements. There is a growing list of companies that offer hybrid models aimed at both raising awareness of new games and monetization optimization. As games and associated monetization models evolve, the relevance of underlying analytics to identify segments of players, how they play, propensity to click on an in-game ad, or pay cash for virtual goods becomes exponentially greater. Current providers offer standard metrics, and some of these vendors, such as Flurry and Kiip, offer virtual good or ad-recommendation optimization engines. While the game analytics industry is making big strides towards catching up, it is still arguably in its infancy. Stores of virtually untapped social data reserves at the player ID level exist as potential predictors that can be tied to segmentation and propensity to purchase models that can drive value-based game development, localization, targeted in-game offers, and ads. This social data can also measure the success of net promoter scores, identify player evangelists, and track redemption of in-game offers.
In addition to the mainstream game monetization approaches detailed above, another major marketing trend is emerging that is worth mention, and is also relevant from an advanced game analytics focus. Gamification is one of the hottest enterprise trends for 2012, involving the use of game mechanics and design to motivate people and drive specific behaviors. In a consumer behavior sense, gamification involves the introduction of game elements such as leaderboards, badges, trophies, points, virtual currency and credits, and more to reward desired behaviors. In one such example, Bunchball and IBM® have teamed up to introduce gamification to drive user adoption and engagement in the IBM Connections environment. Healthcare companies such as UnitedHealth Group have integrated gamification and video game strategies to promote the self-management of wellness and healthy behaviors. Gamification is forecasted to receive US$2 billion in direct spending by 2016. As these programs gain popularity and are more widely implemented, game analytics solutions to measure impacts of gamification programs on customer engagement and loyalty will be in demand.
With all of the expected growth around video, social, and mobile games and the increasing enterprise adoption of gamification, one might expect the associated game and gamification analytics solutions to be more mature. A large barrier exists to nimble game-and player-related analytics that has hampered rapid advancements in this space. The sheer mass of in-play, leveling up, skill achievement, in-game purchase, and peripheral game data at the individual player level presents a challenge for traditional database structures. Legacy relational database management systems (RDBMS) were not built to manage, store, and process the petabytes of data generated by modern MMO and mobile or social games. New big data solutions are based on NoSQL technology and are far better suited to manage the rapidly changing data volume, sources, and format of structured, semi-structured, and unstructured data, and filter datasets to a manageable level as an input to on-the-fly analytics solutions.
Technology advancements in databases
Relational databases have been in widespread usage since their introduction onto the scene in the 1970s. While there has been explosive growth in user bases of online applications and resulting data generated from online and mobile systems during this time, new solutions better suited to managing data on such a big scale were not introduced and in wider-spread usage until recently. Different methods of extending the capacity of legacy systems were introduced.
- Sharding is the practice of data partitioning across diverse servers, which requires knowledge of the server location of data and is limited by the fact that you can't perform joins across shards. You must maintain schemas for each server.
- Denormalization is another method that involves grouping and indexing redundant data and often results in latency and issues with maintaining concurrency in relational database systems.
- Distributed caching, which caches recent data in memory, is useful when data is needed. The application (web, game, social network, search engine, and so on) first checks a distributed caching system, such as memcached, for the needed data instead of going back to the relational database.
There are a variety of NoSQL database types, including document stores, column stores, key-value stores, XML databases, and graph databases. There are over 122 NoSQL databases in use, and that number continues to expand. There are several popular open source NoSQL options including column stores, such as Apache CouchDB and MongoDB, and wide-column stores, such as Apache Cassandra, Apache Hadoop, and Hbase. There are also open source analytics tools that sit on top of systems such as Hadoop’s MapReduce paradigm. Apache Mahout is a machine learning engine that provides classification, clustering, and collaborative filtering. Open source R has been integrated to run massively parallel statistical processes directly in Hadoop nodes. Also popular are commercial NoSQL options that integrate with Hadoop and other open source tools and greatly extend these capabilities with analytics, text mining, in-application processing, map reduce functions, and graphing options. One such example is the recently released IBM InfoSphere BigInsights that is built on the Apache Hadoop platform and is available in both a basic no-charge option and a more powerful enterprise edition.
Video game analytics examples
Now it's time to take a look at a couple of real-world game analytics applications. Imagine a large MMO video game. This game genre includes powerhouse games such as World of Warcraft, the most profitable video game in history, and the recently released Star Wars the Old Republic. The video game subscription models fall into a few categories:
- Pay-to-play is where players must pay a monthly subscription fee.
- Free-to-play usually involves an upfront software cost but no additional payments.
- Freemium allows players to access game content and play for free but offers options to pay for additional content and access.
For pay-to-play games, game analytics are focused on understanding who the most valuable players are, how they play, if they evangelize the game and influence others to play, and what their player personalities and motives look like. An important application of propensity modeling in this type of model is to identify those players with the highest propensity to do one of the following:
- Continue a subscription
- Return to play a game after a subscription pause
- Encourage new players to subscribe
- Become skilled and persuasive guild leaders
Microsegmentation applications involve segmenting a player base to understand distinct segment preferences and behaviors to guide targeted game design, localization that reflects preferences of regional segments, and appealing targeted extension packages and additional content design. When you segment a player base and assign players real-time propensity scores, product, design, and marketing have detailed individual player intelligence to guide strategy and back-end measurement. This approach to players of games is no different from the traditional customer view towards applying advanced analytics for player retention, churn, and marketing response efforts. The main difference in this channel is the new variety of data and tremendous volume and velocity at which it is generated. The video game industry stands to benefit as they begin to leverage the efficiencies of combining traditional relationship databases such as Netezza with Hadoop and other NoSQL data stores and apply data mining tools such as R or InfoSphere BigInsights, which effectively manage out-of-memory data processing and analytics.
Mobile and social game analytics examples
Mobile and social game developers have been early adopters of big data technology, cloud computing solutions, and associated data mining applications. Zynga, for example, is well known in the industry for strategy based on cutting-edge player analytics to drive actionable user analysis. Player analytics allows social game studios to understand in real-time why users are abandoning a game and identify other players at risk of leaving the game so they can develop player retention strategies before those players quit. The same analytics applications optimize ad-generated interaction and in-game virtual goods sales. If a game developer is able to identify viral users that spread the player base, they can perform an outreach on social media sites with rewards to ensure the continuation of desired behaviors. Analytics in a mobile setting identifies players who represent the highest value in terms of propensity to purchase virtual goods, evangelize a game, or generate ad revenue. Another major issue with all game genres is game fraud, and analytics uncovers fraudulent player behavior for removal. Mobile and social games employ analytics to understand content and campaigns that work best, often combined with embedded A/B content testing and refinement. Player segmentation based on variables related to device, platform, carrier, geolocation, and demographics facilitate more effective in-game and non-game brand and real-time partner-targeted offers.
Summary
Both the game industry and technology are evolving at a rapid pace. Technological advancements in both sectors provide exciting opportunities for game developers and media studios to apply advanced analytics to further enhance design and optimize game monetization efforts. If new state legislation passes to legalize online gambling, a new focus on advanced analytics and microsegmentation to drive player monetization based on gambling patterns will emerge. Game fraud and analytics to combat this across all game genres will continue to be stressed. As more and more users gravitate to smart phones and tablets, more game business models will move to freemium models, and new player monetization models will emerge that require propensity modeling and segmentation for better targeting. Gamification will continue to spread, and the need for metrics associated with these programs will grow. The next decade promises to be fertile ground for specialized game analytics solutions and analysts focused on incorporating big data technologies to uncover rich insights into both player and consumer behavior.
About the Author
Kimberly Chulis is one of the original founders of Core Analytics, LLC. With over 18 years of professional advanced analytics experience, she's demonstrated analytic expertise on projects at several companies and industries, including WellPoint, HCSC, UHG, Great West, Accenture, Ogilvy, Microsoft, Sprint/Nextel, Commonwealth Edison, TXU, Eloyalty, SPSS, Allstate, Cendant, and others in the financial, telecommunications, healthcare, energy, nonprofit, retail, and educational sectors. Kimberly has conducted PhD research at Purdue University's Health and Human Services Consumer Behavior program, and has a Masters degree in economics with a focus on health economics and econometrics from the University of Illinois at Chicago.
Tuesday, July 24, 2012
Aug 15th, Saratoga Springs, NY: #Cognos Day at the Races
You are cordially invited to attend a unique IBM Business Analytics event in Saratoga Springs. The event will begin a The National Museum of Racing Hall of Fame, where guests an tour the museum's rich history of thoroughbred racing which includes equine art, artifacts, memorabilia, film, video, books, and historical archives.
You will also learn more about the following topics:
- Top 10 in Cognos 10
- Cognos Insight - Individual Desktop Analytics
- Predictive and Advanced Analytics
Complimentary food and beverages will be provided. Following lunch, you will be provided tickets to the race track where you can enjoy horse racing on wonderful afternoon in Saratoga.
Tickets are limited - so register today!
Tickets and parking information will be provided after the RSVP is confirmed.
Co-Sponsored by:
>>> REGISTER HERE <<<
When: Wednesday, August 15th, 2012
- 9:00 AM Registration and Continental Breakfast
- 9:15 AM Cognos Presentations
- 11:30 AM Lunch
- 1:00 PM Belmont
Location: National Museum of Racing Hall of Fame
191 Union Avenue
Saratoga Springs, NY 12866
Thursday, July 19, 2012
Tuesday, May 29, 2012
Thursday, May 24, 2012
Wednesday, May 9, 2012
#InfoSphere Streams Drastically Improves Decision Making #ibm #in
Quickly and continuously analyze massive volumes of data-in-motion to gain insights and drastically improve decision making. Learn more at http://www.ibm.com/software/data/infosphere/streams/.
Monday, May 7, 2012
IBM Smart Analytics System 5710 Installed #analytics #ba #in
In February, I blogged about the IBM Smart Analytics System 5710, an appliance that gives the "little guy" the ability to do "big time" data analytics.
Today, I'd like to show you a video of its ease of installation and use...
Are you in the New York Tri-State Area, New York State, or New England? Contact me today to learn more. jagaeta@us.ibm.com or 770-863-1493.
Today, I'd like to show you a video of its ease of installation and use...
Are you in the New York Tri-State Area, New York State, or New England? Contact me today to learn more. jagaeta@us.ibm.com or 770-863-1493.
Wednesday, April 18, 2012
#Analytics and The Future of #Healthcare
Market-driven reform already shifting emphasis from volume to value as industry leaders weigh in on what’s next.
By Peter Horner and Atanu Basu
This article was originally published in the January/February 2012 edition of Analytics-Magazine.org.
Healthcare will be a hot topic during the 2012 U.S. presidential campaign as the Patient Protection and Affordable Care Act signed into law by President Barack Obama nearly two years ago is attacked or defended by the respective candidates and their surrogates. However, no matter who wins the White House this year, the U.S. healthcare system will be reformed, and more likely transformed, in the near future, and analytics is certain to play a leading role in that transformation. In fact, reform is already well underway, driven by increased competition within the healthcare industry, the trend toward “accountable care” and the realization that spiraling costs make the current system unsustainable.
According to the Centers for Medicare and Medicaid Services, U.S. national health expenditure totaled $2.5 trillion in 2009, or $8,086 per person, and accounted for 17.6 percent of gross domestic product [1]. The United States spends more money per person per year on healthcare than any other nation in the world [2], yet the World Health Organization ranked the U.S. healthcare system 37th in overall performance [3] (just behind Costa Rica and just ahead of Slovenia) in 2000, the last year the rankings were compiled.
Why is healthcare so expensive in the United States and why doesn’t all that money produce better outcomes across the populace? Some of the more notorious contributors to the problem include misaligned incentives among the various stakeholders, bloated administration costs (someone has to shuffle all that paperwork), fraud and abuse, overtreatment and defensive treatment (from fear of malpractice suits), system failures and a lack of coordinated care, almost all of which are target-rich environments for analytical intervention.
To be sure, the United States offers arguably the best healthcare in the world, but at what price? According to the American Journal of Medicine, medical bills capsized 62 percent of the people who went bankrupt in 2007 [4]. Clearly, healthcare in the United States can benefit from a strong dose of analytics to help improve the performance of a massive, complex, fragmented, hugely expensive system struggling to sustain itself.
Volume vs. Value
The U.S. healthcare system has historically operated on a fee-for-service model. The more patients a doctor sees, the more operations a surgeon performs, the more beds a hospital fills, the more money the care provider in question makes. While patient outcomes and experiences are obviously a concern for all involved, they don’t impact the fee schedule. In short, the fee-for-service model emphasizes volume over value. That is about to change.
The mandate requiring individuals to purchase health insurance has turned into a popular talking point for politicians, but the provision of the Accountable Care Act that has caught the attention of the healthcare industry is the one that imposes financial penalties for providers who don’t meet certain standards of care for Medicare and Medicaid patients. The most prominent yardstick is hospital readmissions – patients who come in with certain ailments and then have to be readmitted to the hospital within 30 days after they are discharged. If a hospital’s number of such readmits exceeds a national standard, the hospital will suffer financially in terms of Medicare and Medicaid reimbursements. That means patient outcomes are now part of the healthcare fee structure, which makes it a whole new ball game.
“If I, as a healthcare provider, am now financially at risk if you as a patient have to be readmitted to my hospital within 30 days, it changes the relationship I have with you,” explains Steve Conti, senior director of clinical innovation and population management at Seton Healthcare Family of Hospitals and head of the analytics committee at the Integrated Care Collaboration (ICC), a nonprofit alliance of healthcare providers in Central Texas. “In a fee-for-service environment, the system is not financially affected by how many times you get admitted. It may call into question the quality of the care you receive, but from a purely financial perspective, it is advantageous to have you readmitted. In a value-based system, it’s just the opposite.”
Conti predicts that within five years, the U.S. healthcare industry will move from a largely fee-for-service, volume-based system to a value-based system. “And the way you get to that new type of structure is through analytics,” he says.
ICC, one of the seven highest-rated Health Information Exchanges (HIEs) in the nation, has embraced and employed analytics since the alliance was founded in 1997. In support of its mission to provide high-quality healthcare in a cost-effective manner, particularly for patients who can least afford it, the ICC operates a regional health information exchange called ICare that contains data on more than a million patients and more than 8 million encounters (provider visits) at 70 locations throughout the Central Texas region.
According to Conti, analytics coupled with the wealth of patient data available in ICare enables ICC provider organizations to identify and reduce duplications in services, thus cutting costs and driving value. ICC also uses analytics and a team of epidemiologists and database analysts to measure and assess everything from readmission rates to clinical ventures. The team uses statistical models to compare how its member providers are managing their diabetic care clinics, for example, to see which ones are doing well and where there’s opportunity for improvement.
“Healthcare is too expensive,” Conti concludes. “When we look at the national expenditure for healthcare it becomes pretty evident that it’s unsustainable. As you back out from that, it causes large health organizations to begin to ask the tough questions. How are we contributing to that cost, and what can we do to become a change leader in the process of making healthcare more affordable, more effective, more efficient and more accessible? And the only way we can understand and improve the process is by having strong analytic capabilities.”
Realigning Incentives
Until fairly recently, the provider side of the healthcare industry had been reluctant to embrace analytics. Humans are naturally resistant to change, and doctors are notoriously wary of ceding the control they’ve historically wielded regarding their patients’ diagnoses and treatment to others, let alone a “mathematical model.” After all, who could possibly know a patient’s medical history and issues better than the patient’s personal doctor?
For-profit hospital organizations had reason to resist employing analytics because “optimizing” their systems could theoretically hurt profits. Imagine a major hospital group that used analytics and electronic health records pre-Affordable Care Act to eliminate overtreatment and unnecessary lab tests and imaging, while simultaneously cutting patient queue times, improving patient outcomes and reducing readmissions. At the end of the fiscal year, everyone would be happy except the company CEO, whose bonus is tied to profits and who has to explain a multi-million dollar drop in revenue to shareholders.
Can for-profit organizations prosper in a value-driven healthcare environment? Of course they can. After all, competing on value and service demands efficiency and effectiveness, assumed private sector strong suits in a competitive marketplace. The only question is, are for-profit healthcare organizations willing and able to adapt and change the way they do business and realign their incentives and pay structure to fit the new industry model? With their survival at stake, the likely answer is yes, and big data and analytics are ready to help.
But isn’t the healthcare industry different from, say, manufacturing? You’re talking about healing human beings, not making widgets, and you can’t just apply systems and global optimization techniques in the traditional, industrial engineering sense to the healthcare industry, can you?
“Health is something that is very difficult to quantify,” says Ryan Leslie, Ph.D., vice president of analytics at Seton Family of Hospitals, a network of 31 healthcare facilities throughout Central Texas. Seton is one of the 32 Pioneer Accountable Care Organizations announced by the Centers for Medicare and Medicaid Services in December 2011.
“As emotional human beings, it’s hard for us to be objective when talking about health,” Leslie continues. “By its nature, healthcare has complexities that you don’t necessarily see in other industries. The outcome of a healthcare work process isn’t a widget. You’re doing something with the intent of helping a patient, but the patient is looking subjectively at the whole experience. You may properly treat an illness, but the patient may not like your bedside manner. You may be incapable of treating an illness, but the patient may still be satisfied with the way that you have delivered care. It’s the peculiar nature of the products and services that come out of healthcare.”
Leslie points out that the economics of healthcare also differentiate it from other industries. For example, healthcare predominantly uses a third-party payer system, and supply-and-demand and market and competitive forces do not necessarily work the same way in healthcare as they do in other industries.
“If you look at the high-tech industry, you see innovation right and left because if you’re not constantly transforming and innovating, you’re out of a job tomorrow. With healthcare it’s a little different because there are so many legal barriers to competition. The decision to consume healthcare products and services and the payment for those products and services are so disconnected that you just don’t have the same economic forces that you do in other industries.”
Leslie’s colleague, Conti, offers a different perspective. “What has led us to where we are in healthcare today – rising and unsustainable costs and the resistance to change – is this philosophy that healthcare is different, that it’s unique,” Conti says. “Obviously, caring for people is very different, but if you look at just the process that is involved in moving individuals in, through and out of a hospital or a clinic, it’s very similar to the hospitality industry – a hotel or a restaurant, for example. … The logistics involved in coordinating all the moving parts required for delivering care to an individual are complex and not dissimilar to air traffic control moving airplanes around airports and around the world.
“At ICC,” Conti continues, “we’re trying to create a system that provides whatever care is needed wherever that care is needed across the entire spectrum of delivery venues and throughout the patient’s lifespan. That’s a fundamentally different way of thinking than what would be required in a hospital-only organization.”
Payers vs. Providers
To some extent, insurers/payers are caught in the middle between patients and providers in the healthcare economic tug-of-war. Providers (and economic factors beyond their control) tend to drive healthcare costs up, while patients and employers obviously want to keep their insurance premiums down. Kaiser Permanente is both a provider and a payer that offers healthcare and health insurance under one big roof, which gives Dr. Yan Chow, director of KP’s Innovation and Advanced Technology Group, a unique 360-degree view of the “pay-for-performance” trend in healthcare. Chow also holds an MBA as well as an MD, further cementing his feet in both the business and medical sides of the industry.
So what’s Chow’s take on the changing healthcare landscape and how will analytics shape KP and the industry going forward?
“Over time, payers will push more and more for the collection of data,” he says. “We need data to know what’s going on. We need shared data to integrate a very fractured healthcare system. We need data to better inform physicians and empower consumers.”
Much of that data will come from electronic health records (EHR). In 2003, Kaiser Permanente became one of the first healthcare organizations to install an enterprise-wide EHR system; today the system holds information on nearly nine million patients and continues to gather information at an astonishing rate.
“We have the largest clinical data repository in the world,” Chow says. “It contains more information than the Library of Congress.” Now the trick is to analyze all of that information and turn it into something useful, Chow says, starting with a couple of applications in its integrated care delivery system.
“Even though we are an integrated system, revenue capture remains a big issue for us and for most healthcare providers,” he says. “We want to make sure when we bill Medicare, for example, we receive the reimbursement that is due based on the data collected during a patient’s visit. Beyond that, from both the payer and the provider side, we’re very concerned about the quality of healthcare, so we look very carefully at data for care quality outcomes and plan to use predictive analytics to find out what kind of treatments or courses of treatment work best for different individuals. It’s a highly personalized analysis and it’s all driven by analytics.
“From the payer’s side, we’re looking very closely at efficiency, and that’s all driven by data,” Chow continues. “We collect data on the time it takes to do things, the time it takes to get resources to get where they are needed, the implications of certain kinds of decisions. We use analytical tools to see how we can become more efficient while providing the same or better quality of care. As a very large organization, we look at the data challenge from many points of view, and while different internal groups may have different agendas, we are all on the same page as far as quality, service and affordability goals are concerned.”
Chow expects other healthcare organizations to follow KP’s lead, and suspects the ones who don’t will be left behind.
“With all the information that’s out there, patients are going to be looking at their healthcare situation very carefully and comparing their options,” he says. “In the future, there will be much more visibility and accountability. If another care provider down the street is getting better results than you for the same cost, you’re going to lose patients.”
Big Pharma Perspective
Andy Palmer, co-founder and former president and CEO of Vertica Systems and co-founder of a half-dozen other successful startups over the past 20 years, made his mark and his money as an entrepreneur in analytics, big data and data management software. Today, in addition to his entrepreneurial activities, he spends a considerable amount of his creative, analytical talent on the life sciences, working with companies such as pharmaceutical giant Novartis (as an executive director) in the area of drug discovery. Palmer has a particular passion for cancer research. For example, he served as an advisor to the Lance Armstrong Foundation on the development of an iPad app for cancer patients.
“Drug discovery and research is a fundamentally interdisciplinary activity that requires scientists on a daily basis to integrate information from across many different organizations and many different scientific disciplines,” Palmer says. “I think of it as the hardest analytical and data integration environment on the planet, but also one that offers the biggest benefit: finding important new medicines for patients with unmet medical needs.”
The bottom line for any pharma company is developing new and more effective drugs and getting them to the marketplace as soon as possible, given all the research and clinical trials that are typically involved. How does analytics help make that happen?
“Pharmaceutical companies make decisions every day on where they are going to invest research dollars,” Palmer says. “It’s a huge distraction and waste of time, energy and effort to start a new clinical trial only to find that there are not enough patients out there in the general population to make the trial successful. It’s important to make sure that we are investing our dollars and our energy as efficiently as possible, and that we’re making the best possible decisions so that we can effectively discover new drugs for patients.
“Every decision should be analytically and data-driven: which trials to run, how those trials are going to be run, where they are going to be run, which patients to recruit for which trials. All of these things should be reviewed in an integrated way. It’s a very challenging analytics and big data problem.”
Chronic Diseases and Telehealth
According to the Centers for Disease Control and Prevention (CDC), chronic disease accounts for about 75 percent of U.S. aggregate healthcare spending [5], which makes chronic disease an attractive target for any entity interested in reducing national healthcare costs. Since unhealthy behavior and non-adherence to prescribed meds often results in complications involving chronic diseases such as diabetes, the concept of telehealth is one way to improve chronic disease management, yet it, too, has run into resistance in certain segments of the medical community.
Unlike traditional medical intervention that basically stops when the doctor writes a prescription (at least until complications commence), telehealth is a means for healthcare providers to continuously reach out to patients through telecommunication technology. Telehealth can be as simple as sending an e-mail reminder to chronic care patients to take their meds, or it can be an intensive monitoring and information exchange system using sophisticated software systems and online questionnaires to ascertain a patient’s health status and to discover early on if the patient is developing a problem – all without the patient ever visiting the doctor’s office.
Adherence to meds and early detection of potential problems translate into fewer complications and fewer emergency room visits, according to a 2011 study published in the policy journal Health Affairs. In the study, Stanford University researchers, reporting on a telehealth demonstration project involving 1,700 Medicare patients with various chronic diseases, found that a telehealth system trimmed spending by 7.7 percent to 13.3 percent, or $312 to $542 per person, each quarter [6].
Dr. Jasper zu Putlitz is president of Palo Alto, Calif.-based Robert Bosch Healthcare, developers of the telehealth system used in the demonstration project cited in Health Affairs. “I think that telehealth will be an integral part of healthcare in the future, not only in developed countries such as the United States, but in emerging countries like India where access to healthcare is really an issue,” he says. The prevalence of smart phones around the world, even in many emerging countries, enhances the capability of telehealth as a versatile, viable delivery system.
Dr. zu Putlitz, a medical doctor by training who practiced internal medicine in Germany and Switzerland for seven years, envisions that telehealth systems will be integrated with electronic medical records and health information exchanges, creating a wealth of integrated data and opening up a world of opportunities for analytics. “You want to be really smart about how you analyze the data,” zu Putlitz cautions. “Whatever we do in analytics should be about enabling the physician to make the right decision. The goal is to take all of the data and create a prediction around what a particular patient will require next and make it a very personalized intervention.”
To date, relatively few healthcare organizations have adopted telehealth. Ironically, one of the reasons often cited is the perceived “non-personal” nature of the technology, but that perception is beginning to change, says zu Putlitz. “Doctors, especially those affiliated with larger healthcare systems, are starting to appreciate all the benefits that come from additional information and all the things that technology can do for them,” he says. “Clearly, there’s still reluctance from doctors who feel that this technology might take away from the patient-doctor relationship, but once they see how teleheatlh actually enables them to take care of their patients in a better, more efficient way, they change their minds.”
No one has to convince the Veterans Health Administration, which runs the largest and one of the most cost-effective healthcare systems in the United States [7], about the merits of telehealth. The VA has been a Bosch customer for 11 years and just extended its contract for another five years. “The VA is absolutely a trailblazer in the use of analytics and telehealth,” zu Putlitz says. “What they are doing with our technology is clearly impressive. They published a study linking telehealth and 17,000 VA patients with chronic disease that showed a tremendous impact – nearly a 20 percent reduction in hospital admissions.” [8].
Bottom Line on Healthcare Reform
The transformation of U.S. healthcare from volume-based system to a value-based system – with the goal of improving efficiency, access and outcomes while reducing costs – demands the realignment of stakeholder incentives and the development of a new payment structure that rewards those collective goals for all concerned.
“The changes that are taking place at the national level are fundamentally changing the way the healthcare system is organized and aligned,” says ICC’s Conti. “Whether it’s a healthcare system, an insurance company or a pharmaceutical company, all three of these players can no longer function in silos. They are going to be aligning themselves in a way that lowers the cost for the entire system and drives value for the individual patient.”
“It’s in the interest of both providers and payers to change their business model to fit the new environment,” says Kaiser Permanente’s Chow. “Costs concerns, resource restraints, increasing demand, better technology – all of these factors will cause change. The people who survive will be the people who can figure out how to adapt. Many consumers are ready to accept a new model of care. Eventually it will have to happen. We don’t have enough doctors and nurses. We don’t have the resources to keep charging for things that we can’t pay for.”
“When healthcare becomes more analytics-based and maybe a little less subjective on a population level, there will be savings and there will be efficiency gains,” adds Bosch’s zu Putlitz. “The payer (insurer) is almost naturally incentivized to do it because the savings would show up where the risk is sitting. The provider side – doctors and hospitals – will see better outcomes. Improving the care of patients is a very strong argument, and it’s a way for providers to differentiate themselves in a crowded, competitive market. Providers are talking to us because they are being held accountable and need to demonstrate quality and value in this new environment.”
And what about the patient, the presumed focus of healthcare reform in the first place?
“If we do it right and healthcare organizations really use advanced analytics to drive better access, quality and outcomes, you as a patient are going to derive more value from the healthcare system,” Conti concludes. “Along with better care and better outcomes, you will get more value for every dollar you spend on healthcare, whether it’s on a doctor, a pill or an insurance plan. The ultimate metric is ‘health per dollar.’ Over time, that will become the gold standard for healthcare.”
Along those same lines, entrepreneur/technologist Palmer gets the last word: “Five years from now we’re going to look back and realize that the companies that adopted predictive and prescriptive analytics are the ones that are going to have a significant advantage in the market. And I think there is no more important application of these high-end analytical technologies and capabilities than developing new, more effective therapies and improving healthcare for patients.”
Peter Horner (horner@lionhrtpub.com) is the editor of Analytics and OR/MS Today, the magazine of membership of the Institute for Operations Research and the Management Sciences.
Atanu Basu (atanu.basu@ayata.com) is the founder and of CEO of Ayata, a prescriptive analytics® software company whose customers include Dell, Cisco and Microsoft.
References
By Peter Horner and Atanu Basu
This article was originally published in the January/February 2012 edition of Analytics-Magazine.org.
Healthcare will be a hot topic during the 2012 U.S. presidential campaign as the Patient Protection and Affordable Care Act signed into law by President Barack Obama nearly two years ago is attacked or defended by the respective candidates and their surrogates. However, no matter who wins the White House this year, the U.S. healthcare system will be reformed, and more likely transformed, in the near future, and analytics is certain to play a leading role in that transformation. In fact, reform is already well underway, driven by increased competition within the healthcare industry, the trend toward “accountable care” and the realization that spiraling costs make the current system unsustainable.
According to the Centers for Medicare and Medicaid Services, U.S. national health expenditure totaled $2.5 trillion in 2009, or $8,086 per person, and accounted for 17.6 percent of gross domestic product [1]. The United States spends more money per person per year on healthcare than any other nation in the world [2], yet the World Health Organization ranked the U.S. healthcare system 37th in overall performance [3] (just behind Costa Rica and just ahead of Slovenia) in 2000, the last year the rankings were compiled.
Why is healthcare so expensive in the United States and why doesn’t all that money produce better outcomes across the populace? Some of the more notorious contributors to the problem include misaligned incentives among the various stakeholders, bloated administration costs (someone has to shuffle all that paperwork), fraud and abuse, overtreatment and defensive treatment (from fear of malpractice suits), system failures and a lack of coordinated care, almost all of which are target-rich environments for analytical intervention.
To be sure, the United States offers arguably the best healthcare in the world, but at what price? According to the American Journal of Medicine, medical bills capsized 62 percent of the people who went bankrupt in 2007 [4]. Clearly, healthcare in the United States can benefit from a strong dose of analytics to help improve the performance of a massive, complex, fragmented, hugely expensive system struggling to sustain itself.
Volume vs. Value
The U.S. healthcare system has historically operated on a fee-for-service model. The more patients a doctor sees, the more operations a surgeon performs, the more beds a hospital fills, the more money the care provider in question makes. While patient outcomes and experiences are obviously a concern for all involved, they don’t impact the fee schedule. In short, the fee-for-service model emphasizes volume over value. That is about to change.
The mandate requiring individuals to purchase health insurance has turned into a popular talking point for politicians, but the provision of the Accountable Care Act that has caught the attention of the healthcare industry is the one that imposes financial penalties for providers who don’t meet certain standards of care for Medicare and Medicaid patients. The most prominent yardstick is hospital readmissions – patients who come in with certain ailments and then have to be readmitted to the hospital within 30 days after they are discharged. If a hospital’s number of such readmits exceeds a national standard, the hospital will suffer financially in terms of Medicare and Medicaid reimbursements. That means patient outcomes are now part of the healthcare fee structure, which makes it a whole new ball game.
“If I, as a healthcare provider, am now financially at risk if you as a patient have to be readmitted to my hospital within 30 days, it changes the relationship I have with you,” explains Steve Conti, senior director of clinical innovation and population management at Seton Healthcare Family of Hospitals and head of the analytics committee at the Integrated Care Collaboration (ICC), a nonprofit alliance of healthcare providers in Central Texas. “In a fee-for-service environment, the system is not financially affected by how many times you get admitted. It may call into question the quality of the care you receive, but from a purely financial perspective, it is advantageous to have you readmitted. In a value-based system, it’s just the opposite.”
Conti predicts that within five years, the U.S. healthcare industry will move from a largely fee-for-service, volume-based system to a value-based system. “And the way you get to that new type of structure is through analytics,” he says.
ICC, one of the seven highest-rated Health Information Exchanges (HIEs) in the nation, has embraced and employed analytics since the alliance was founded in 1997. In support of its mission to provide high-quality healthcare in a cost-effective manner, particularly for patients who can least afford it, the ICC operates a regional health information exchange called ICare that contains data on more than a million patients and more than 8 million encounters (provider visits) at 70 locations throughout the Central Texas region.
According to Conti, analytics coupled with the wealth of patient data available in ICare enables ICC provider organizations to identify and reduce duplications in services, thus cutting costs and driving value. ICC also uses analytics and a team of epidemiologists and database analysts to measure and assess everything from readmission rates to clinical ventures. The team uses statistical models to compare how its member providers are managing their diabetic care clinics, for example, to see which ones are doing well and where there’s opportunity for improvement.
“Healthcare is too expensive,” Conti concludes. “When we look at the national expenditure for healthcare it becomes pretty evident that it’s unsustainable. As you back out from that, it causes large health organizations to begin to ask the tough questions. How are we contributing to that cost, and what can we do to become a change leader in the process of making healthcare more affordable, more effective, more efficient and more accessible? And the only way we can understand and improve the process is by having strong analytic capabilities.”
Realigning Incentives
Until fairly recently, the provider side of the healthcare industry had been reluctant to embrace analytics. Humans are naturally resistant to change, and doctors are notoriously wary of ceding the control they’ve historically wielded regarding their patients’ diagnoses and treatment to others, let alone a “mathematical model.” After all, who could possibly know a patient’s medical history and issues better than the patient’s personal doctor?
For-profit hospital organizations had reason to resist employing analytics because “optimizing” their systems could theoretically hurt profits. Imagine a major hospital group that used analytics and electronic health records pre-Affordable Care Act to eliminate overtreatment and unnecessary lab tests and imaging, while simultaneously cutting patient queue times, improving patient outcomes and reducing readmissions. At the end of the fiscal year, everyone would be happy except the company CEO, whose bonus is tied to profits and who has to explain a multi-million dollar drop in revenue to shareholders.
Can for-profit organizations prosper in a value-driven healthcare environment? Of course they can. After all, competing on value and service demands efficiency and effectiveness, assumed private sector strong suits in a competitive marketplace. The only question is, are for-profit healthcare organizations willing and able to adapt and change the way they do business and realign their incentives and pay structure to fit the new industry model? With their survival at stake, the likely answer is yes, and big data and analytics are ready to help.
But isn’t the healthcare industry different from, say, manufacturing? You’re talking about healing human beings, not making widgets, and you can’t just apply systems and global optimization techniques in the traditional, industrial engineering sense to the healthcare industry, can you?
“Health is something that is very difficult to quantify,” says Ryan Leslie, Ph.D., vice president of analytics at Seton Family of Hospitals, a network of 31 healthcare facilities throughout Central Texas. Seton is one of the 32 Pioneer Accountable Care Organizations announced by the Centers for Medicare and Medicaid Services in December 2011.
“As emotional human beings, it’s hard for us to be objective when talking about health,” Leslie continues. “By its nature, healthcare has complexities that you don’t necessarily see in other industries. The outcome of a healthcare work process isn’t a widget. You’re doing something with the intent of helping a patient, but the patient is looking subjectively at the whole experience. You may properly treat an illness, but the patient may not like your bedside manner. You may be incapable of treating an illness, but the patient may still be satisfied with the way that you have delivered care. It’s the peculiar nature of the products and services that come out of healthcare.”
Leslie points out that the economics of healthcare also differentiate it from other industries. For example, healthcare predominantly uses a third-party payer system, and supply-and-demand and market and competitive forces do not necessarily work the same way in healthcare as they do in other industries.
“If you look at the high-tech industry, you see innovation right and left because if you’re not constantly transforming and innovating, you’re out of a job tomorrow. With healthcare it’s a little different because there are so many legal barriers to competition. The decision to consume healthcare products and services and the payment for those products and services are so disconnected that you just don’t have the same economic forces that you do in other industries.”
Leslie’s colleague, Conti, offers a different perspective. “What has led us to where we are in healthcare today – rising and unsustainable costs and the resistance to change – is this philosophy that healthcare is different, that it’s unique,” Conti says. “Obviously, caring for people is very different, but if you look at just the process that is involved in moving individuals in, through and out of a hospital or a clinic, it’s very similar to the hospitality industry – a hotel or a restaurant, for example. … The logistics involved in coordinating all the moving parts required for delivering care to an individual are complex and not dissimilar to air traffic control moving airplanes around airports and around the world.
“At ICC,” Conti continues, “we’re trying to create a system that provides whatever care is needed wherever that care is needed across the entire spectrum of delivery venues and throughout the patient’s lifespan. That’s a fundamentally different way of thinking than what would be required in a hospital-only organization.”
Payers vs. Providers
To some extent, insurers/payers are caught in the middle between patients and providers in the healthcare economic tug-of-war. Providers (and economic factors beyond their control) tend to drive healthcare costs up, while patients and employers obviously want to keep their insurance premiums down. Kaiser Permanente is both a provider and a payer that offers healthcare and health insurance under one big roof, which gives Dr. Yan Chow, director of KP’s Innovation and Advanced Technology Group, a unique 360-degree view of the “pay-for-performance” trend in healthcare. Chow also holds an MBA as well as an MD, further cementing his feet in both the business and medical sides of the industry.
So what’s Chow’s take on the changing healthcare landscape and how will analytics shape KP and the industry going forward?
“Over time, payers will push more and more for the collection of data,” he says. “We need data to know what’s going on. We need shared data to integrate a very fractured healthcare system. We need data to better inform physicians and empower consumers.”
Much of that data will come from electronic health records (EHR). In 2003, Kaiser Permanente became one of the first healthcare organizations to install an enterprise-wide EHR system; today the system holds information on nearly nine million patients and continues to gather information at an astonishing rate.
“We have the largest clinical data repository in the world,” Chow says. “It contains more information than the Library of Congress.” Now the trick is to analyze all of that information and turn it into something useful, Chow says, starting with a couple of applications in its integrated care delivery system.
“Even though we are an integrated system, revenue capture remains a big issue for us and for most healthcare providers,” he says. “We want to make sure when we bill Medicare, for example, we receive the reimbursement that is due based on the data collected during a patient’s visit. Beyond that, from both the payer and the provider side, we’re very concerned about the quality of healthcare, so we look very carefully at data for care quality outcomes and plan to use predictive analytics to find out what kind of treatments or courses of treatment work best for different individuals. It’s a highly personalized analysis and it’s all driven by analytics.
“From the payer’s side, we’re looking very closely at efficiency, and that’s all driven by data,” Chow continues. “We collect data on the time it takes to do things, the time it takes to get resources to get where they are needed, the implications of certain kinds of decisions. We use analytical tools to see how we can become more efficient while providing the same or better quality of care. As a very large organization, we look at the data challenge from many points of view, and while different internal groups may have different agendas, we are all on the same page as far as quality, service and affordability goals are concerned.”
Chow expects other healthcare organizations to follow KP’s lead, and suspects the ones who don’t will be left behind.
“With all the information that’s out there, patients are going to be looking at their healthcare situation very carefully and comparing their options,” he says. “In the future, there will be much more visibility and accountability. If another care provider down the street is getting better results than you for the same cost, you’re going to lose patients.”
Big Pharma Perspective
Andy Palmer, co-founder and former president and CEO of Vertica Systems and co-founder of a half-dozen other successful startups over the past 20 years, made his mark and his money as an entrepreneur in analytics, big data and data management software. Today, in addition to his entrepreneurial activities, he spends a considerable amount of his creative, analytical talent on the life sciences, working with companies such as pharmaceutical giant Novartis (as an executive director) in the area of drug discovery. Palmer has a particular passion for cancer research. For example, he served as an advisor to the Lance Armstrong Foundation on the development of an iPad app for cancer patients.
“Drug discovery and research is a fundamentally interdisciplinary activity that requires scientists on a daily basis to integrate information from across many different organizations and many different scientific disciplines,” Palmer says. “I think of it as the hardest analytical and data integration environment on the planet, but also one that offers the biggest benefit: finding important new medicines for patients with unmet medical needs.”
The bottom line for any pharma company is developing new and more effective drugs and getting them to the marketplace as soon as possible, given all the research and clinical trials that are typically involved. How does analytics help make that happen?
“Pharmaceutical companies make decisions every day on where they are going to invest research dollars,” Palmer says. “It’s a huge distraction and waste of time, energy and effort to start a new clinical trial only to find that there are not enough patients out there in the general population to make the trial successful. It’s important to make sure that we are investing our dollars and our energy as efficiently as possible, and that we’re making the best possible decisions so that we can effectively discover new drugs for patients.
“Every decision should be analytically and data-driven: which trials to run, how those trials are going to be run, where they are going to be run, which patients to recruit for which trials. All of these things should be reviewed in an integrated way. It’s a very challenging analytics and big data problem.”
Chronic Diseases and Telehealth
According to the Centers for Disease Control and Prevention (CDC), chronic disease accounts for about 75 percent of U.S. aggregate healthcare spending [5], which makes chronic disease an attractive target for any entity interested in reducing national healthcare costs. Since unhealthy behavior and non-adherence to prescribed meds often results in complications involving chronic diseases such as diabetes, the concept of telehealth is one way to improve chronic disease management, yet it, too, has run into resistance in certain segments of the medical community.
Unlike traditional medical intervention that basically stops when the doctor writes a prescription (at least until complications commence), telehealth is a means for healthcare providers to continuously reach out to patients through telecommunication technology. Telehealth can be as simple as sending an e-mail reminder to chronic care patients to take their meds, or it can be an intensive monitoring and information exchange system using sophisticated software systems and online questionnaires to ascertain a patient’s health status and to discover early on if the patient is developing a problem – all without the patient ever visiting the doctor’s office.
Adherence to meds and early detection of potential problems translate into fewer complications and fewer emergency room visits, according to a 2011 study published in the policy journal Health Affairs. In the study, Stanford University researchers, reporting on a telehealth demonstration project involving 1,700 Medicare patients with various chronic diseases, found that a telehealth system trimmed spending by 7.7 percent to 13.3 percent, or $312 to $542 per person, each quarter [6].
Dr. Jasper zu Putlitz is president of Palo Alto, Calif.-based Robert Bosch Healthcare, developers of the telehealth system used in the demonstration project cited in Health Affairs. “I think that telehealth will be an integral part of healthcare in the future, not only in developed countries such as the United States, but in emerging countries like India where access to healthcare is really an issue,” he says. The prevalence of smart phones around the world, even in many emerging countries, enhances the capability of telehealth as a versatile, viable delivery system.
Dr. zu Putlitz, a medical doctor by training who practiced internal medicine in Germany and Switzerland for seven years, envisions that telehealth systems will be integrated with electronic medical records and health information exchanges, creating a wealth of integrated data and opening up a world of opportunities for analytics. “You want to be really smart about how you analyze the data,” zu Putlitz cautions. “Whatever we do in analytics should be about enabling the physician to make the right decision. The goal is to take all of the data and create a prediction around what a particular patient will require next and make it a very personalized intervention.”
To date, relatively few healthcare organizations have adopted telehealth. Ironically, one of the reasons often cited is the perceived “non-personal” nature of the technology, but that perception is beginning to change, says zu Putlitz. “Doctors, especially those affiliated with larger healthcare systems, are starting to appreciate all the benefits that come from additional information and all the things that technology can do for them,” he says. “Clearly, there’s still reluctance from doctors who feel that this technology might take away from the patient-doctor relationship, but once they see how teleheatlh actually enables them to take care of their patients in a better, more efficient way, they change their minds.”
No one has to convince the Veterans Health Administration, which runs the largest and one of the most cost-effective healthcare systems in the United States [7], about the merits of telehealth. The VA has been a Bosch customer for 11 years and just extended its contract for another five years. “The VA is absolutely a trailblazer in the use of analytics and telehealth,” zu Putlitz says. “What they are doing with our technology is clearly impressive. They published a study linking telehealth and 17,000 VA patients with chronic disease that showed a tremendous impact – nearly a 20 percent reduction in hospital admissions.” [8].
Bottom Line on Healthcare Reform
The transformation of U.S. healthcare from volume-based system to a value-based system – with the goal of improving efficiency, access and outcomes while reducing costs – demands the realignment of stakeholder incentives and the development of a new payment structure that rewards those collective goals for all concerned.
“The changes that are taking place at the national level are fundamentally changing the way the healthcare system is organized and aligned,” says ICC’s Conti. “Whether it’s a healthcare system, an insurance company or a pharmaceutical company, all three of these players can no longer function in silos. They are going to be aligning themselves in a way that lowers the cost for the entire system and drives value for the individual patient.”
“It’s in the interest of both providers and payers to change their business model to fit the new environment,” says Kaiser Permanente’s Chow. “Costs concerns, resource restraints, increasing demand, better technology – all of these factors will cause change. The people who survive will be the people who can figure out how to adapt. Many consumers are ready to accept a new model of care. Eventually it will have to happen. We don’t have enough doctors and nurses. We don’t have the resources to keep charging for things that we can’t pay for.”
“When healthcare becomes more analytics-based and maybe a little less subjective on a population level, there will be savings and there will be efficiency gains,” adds Bosch’s zu Putlitz. “The payer (insurer) is almost naturally incentivized to do it because the savings would show up where the risk is sitting. The provider side – doctors and hospitals – will see better outcomes. Improving the care of patients is a very strong argument, and it’s a way for providers to differentiate themselves in a crowded, competitive market. Providers are talking to us because they are being held accountable and need to demonstrate quality and value in this new environment.”
And what about the patient, the presumed focus of healthcare reform in the first place?
“If we do it right and healthcare organizations really use advanced analytics to drive better access, quality and outcomes, you as a patient are going to derive more value from the healthcare system,” Conti concludes. “Along with better care and better outcomes, you will get more value for every dollar you spend on healthcare, whether it’s on a doctor, a pill or an insurance plan. The ultimate metric is ‘health per dollar.’ Over time, that will become the gold standard for healthcare.”
Along those same lines, entrepreneur/technologist Palmer gets the last word: “Five years from now we’re going to look back and realize that the companies that adopted predictive and prescriptive analytics are the ones that are going to have a significant advantage in the market. And I think there is no more important application of these high-end analytical technologies and capabilities than developing new, more effective therapies and improving healthcare for patients.”
Peter Horner (horner@lionhrtpub.com) is the editor of Analytics and OR/MS Today, the magazine of membership of the Institute for Operations Research and the Management Sciences.
Atanu Basu (atanu.basu@ayata.com) is the founder and of CEO of Ayata, a prescriptive analytics® software company whose customers include Dell, Cisco and Microsoft.
References
- https://www.cms.gov/NationalHealthExpendData/25_NHE_Fact_Sheet.asp
- http://en.wikipedia.org/wiki/Health_care_in_the_United_States
- http://www.photius.com/rankings/healthranks.html
- http://www.pnhp.org/new_bankruptcy_study/Bankruptcy-2009.pdf
- http://www.fightchronicdisease.org/facing-issues/about-crisis
- http://content.healthaffairs.org/content/30/9/1689.abstract
- http://www.himss.org/foundation/docs/rachelmayo.pdf
- http://www.viterion.com/web_docs/VA%20CCS%20Outcomes%20Dec_2008_Darkins.pdf
Thursday, April 12, 2012
Think INSIDE the Box #bigdata #netezza #analytics #in
If you think an IBM Netezza solution for data warehousing and predictive analytics is too expensive for your business, think again. Think "inside the box" and explore the benefits and the total cost of ownership of an IBM Netezza solution here.
Joe Gaeta
jagaeta@us.ibm.com
770-863-1493
Joe Gaeta
jagaeta@us.ibm.com
770-863-1493
Thursday, April 5, 2012
Subscribe to:
Posts (Atom)



